期刊文献+

文拉法辛缓释片与氟西汀治疗抑郁症的临床疗效比较 被引量:5

下载PDF
导出
摘要 目的比较文拉法辛缓释片与氟西汀治疗抑郁症的临床疗效和不良反应。方法对162例抑郁症随机分为两组,分别给予文拉法辛缓释片与氟西汀治疗6周,采用汉密顿抑郁量表(HAMD),汉密顿焦虑量表(HAMA),评定疗效,分别于治疗前及治疗第一、二、四、六周末各评定1次,并进行对比分析。用副反应量表(TESS)评定不良反应。结果文拉法辛组有效率为90%,不良反应少而轻,安全性好,与氟西汀组比较差异无显著性。结论文拉法辛缓释片是一种安全有效的抗抑郁药。
出处 《海峡药学》 2012年第3期133-134,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献6

  • 1何柱国,蔡广惠,戴俊平,张璐璐.文拉法辛缓释剂治疗抑郁状态疗效分析[J].临床精神医学杂志,2005,15(1):45-45. 被引量:17
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M]济南:山东科学技术出版社,200189-91.
  • 3Dinan TG. Efficacy and safety of weekly treatment with entericcoated fluoxetine in patients with major depressive disorder[J].Journal of Clinical Psychiatry,2001,(22):48.
  • 4Hong CJ,Hu WH,Chen CC. A doubleblind、 randomized、groupcomparative study of the tolerability and efficacy of 6 weeks,treatment with mirtazapine or fluoxetine in depressed Chinese patients[J].Journal of Clinical Psychiatry,2003,(08):921.doi:10.4088/JCP.v64n0810.
  • 5Dalery J,Honig A. Fluvoxamine versus fluoxetine in major depressive episode:a doubleblind randomize comparison[J].Human Psychopharmacology,2003,(05):379.doi:10.1002/hup.490.
  • 6周云芳,陈志恩,吴素琴.文拉法辛治疗抑郁症40例[J].医药导报,2006,25(2):137-138. 被引量:4

二级参考文献7

  • 1Femier IN. Treatment of depressive disorder: improvement enough? [ J]J Clin Psychiatry, 1999,60(Suppl 6): 10-14.
  • 2Rudolph RL, Feiger AD. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release(XR) and fluoxetion for the treatment of dep~ssion [ J]. J Affec t Disord, 1999,56:171-181.
  • 3Cunnigham L A. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression[J]. Ann Clln Psychlatry ,1997 ,9 :15 7 -158.
  • 4Silverstone P H, Ravindran A, Once-daily venlafaxine extended release(XR) compared with fluoxetine in outpatients with depression and anxiety [ J ]. J Clin Psychiatry, 1999,60:22 - 23.
  • 5Feigher J P. Mechanism of action of antidepressant medication [ J ]. J Clin Psychiatry, 1999,60(Suppl 4) :4 - 10.
  • 6Fawcett J. The detection and consequence of anxiety in clinical depression [ J]. J Clin Psychiatry, 1997,58( Suppl 8 ) :35-57.
  • 7林建荣,黄煜坤,余金龙,黄杰平,李洁仪.文拉法辛治疗抑郁症74例[J].中国新药与临床杂志,2000,19(5):375-377. 被引量:24

共引文献19

同被引文献33

  • 1杨丽蓉,王志纲.文拉法辛治疗抑郁症的研究进展[J].北方药学,2010,7(1):31-33. 被引量:6
  • 2张勇军 孟家眉.脑卒中后抑郁症的前瞻性研究.国际精神病学杂志,2008,35(2):73-73.
  • 3沈渔哪.精神病学[M].第5版.北京:人民卫生出版社,2009:852.
  • 4Chen X, Du MQ, Fan MW, et al. Caries-preventive effect of sealants pro- duced with altered glass-ionomer materials, after 2 years [ J ]. Dent Ma- ter,2012,28(5 ) :554 -560.
  • 5Fan Y, Liu J, Wang D, et al. Epimedium polysaccharide and propolis fla- vone can synergistically inhibit the cellular infectivity of NDV and im- prove the curative effect of ND in chicken [ J ]. Int J Biol Macromol,2011,48(3) :439 -444.
  • 6赵贤芳.抑郁症的诊断及治疗[J].内蒙古民族大学学报(自然科学版),2007,22(6):657-659. 被引量:9
  • 7Shirley A.Thomas and Nadina B.Lincoln.Predictors of Emotional Distress After Stroke[J].Stroke,2008,39(4):1240-1245.
  • 8Fang J,Cheng Q.Etiological mechanisms of post stroke depression:a review[J].Neurol RES,2009,72(6):643.
  • 9季波,何龙锦,唐涌.黛力新治疗脑卒中后抑郁的疗效观察[J].中国实用神经疾病杂志,2008,11(2):116-117. 被引量:32
  • 10Tamasi V, Petschner P, Adori C, et al. Transcriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplastieity including also glutatmatergic- and insulin- mediated neuronal processes E Jl. PLoS One, 2014, 9(11) =113 662.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部